EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-14-0660-t
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

New Agents for Acute Myelogenous Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

P53 in Chronic Myelogenous Leukemia in Acute Phase.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

DNA Damage in Acute Myeloid Leukemia Patients of Northern Mexico

European Journal of Histochemistry
MedicineCell BiologyHistologyBiophysics
2017English

Treatment of Acute Myelogenous Leukemia in Older Adults

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Differentiation Therapy in Acute Myelogenous Leukemia (Non-Apl)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Acute Myelogenous Leukemia With Leptotrichia Trevisanii Bacteremia

Internal Medicine
Internal MedicineMedicine
2013English

DNA Damage on the DOCK in FLT3-ITD-driven Acute Myeloid Leukemia

Haematologica
Hematology
2019English

Molecular Pathways: Targeting NRAS in Melanoma and Acute Myelogenous Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2014English

Leukemic Retinophaty, the First Manifestation in a Case of Acute Myelogenous Leukemia

Romanian journal of ophthalmology
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy